Up-regulation of β-chemokines and down-modulation of CCR5 co-receptors inhibit simian immunodeficiency virus transmission in non-human primates
- 1 April 2000
- journal article
- research article
- Published by Wiley in Immunology
- Vol. 99 (4) , 569-577
- https://doi.org/10.1046/j.1365-2567.2000.00993.x
Abstract
A non-cognate mechanism of protection against human immunodeficiency virus-1 (HIV-1) infection involves up-regulation of β-chemokines, which bind and may down-modulate the CCR5 co-receptors, thereby preventing transmission of M-tropic HIV-1. The objective of this investigation was to evaluate this mechanism in vivo in non-human primates. Rhesus macaques were immunized by a modified targeted lymph nodes (TLN) route with recombinant simian immunodeficiency virus (SIV) glycoprotein 120 (gp120) and p27 in alum, and adsorbed recombinant granulocyte–macrophage colony-stimulating factor (GM-CSF) with either interleukin (IL)-2 or IL-4. Immunization induced significant increases in the concentrations of CD8 cell-derived suppressor factor (CD8-SF), regulated on activation normal T cells expressed and secreted (RANTES), macrophage inflammatory protein (MIP)-1α and MIP-1β, and down-modulation of the proportion of cells expressing CCR5 (r = 0·737, P < 0·05). The macaques were then challenged with SIVmac 220 by the rectal mucosal route. The plasma SIVmac RNA showed a significant inverse correlation with the CD8-SF or the concentration of the three β-chemokines (r = 0·831 and 0·824, P < 0·01), but a positive correlation between the proportion of CCR5+ cells and SIVmac RNA (r = 0·613, P = 0·05). These results demonstrate for the first time in vivo that immunization up-regulates β-chemokines, which may down-modulate CCR5 co-receptors, and both functions are significantly correlated with the viral load. Hence, the non-cognate β-chemokine–CCR5 mechanism should be considered as complementary to specific immunity in vaccination against HIV.Keywords
This publication has 33 references indexed in Scilit:
- Anti-Major Histocompatibility Complex Antibody Responses to Simian B Cells Do Not Protect Macaques against SIVmacInfectionAIDS Research and Human Retroviruses, 1997
- STRL33, A Novel Chemokine Receptor–like Protein, Functions as a Fusion Cofactor for Both Macrophage-tropic and T Cell Line–tropic HIV-1The Journal of Experimental Medicine, 1997
- Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural GeneScience, 1996
- Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor geneNature, 1996
- Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques.The Journal of Experimental Medicine, 1996
- Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8 + T CellsScience, 1995
- The role of adjuvants in retroviral vaccinesInternational Journal of Immunopharmacology, 1995
- Future uses of granulocyte‐macrophage colony‐stimulating factor (GM‐CSF)The International Journal of Cell Cloning, 1994
- Induction of Mucosal and Systemic Immunity to a Recombinant Simian Immunodeficiency Viral ProteinScience, 1992
- CD8 + Lymphocytes Can Control HIV Infection in Vitro by Suppressing Virus ReplicationScience, 1986